Clindamycin release determined by high performance liquid chromatography from a novel low-cost local drug delivery system

A new potential treatment option for chronic osteomyelitis

D. Frank, G. Montskó, I. Juricskay, B. Borsiczky, G. Cseh, B. Kocsis, T. Nagy, A. K. Nagy, G. Kovács, A. Miseta

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Osteomyelitis continues to be a severe problem worldwide, causing plenty of hospital admissions and entailing vast expenses. previously, we developed a low-cost polymethyl-methacrylate (pmmA)-sorbitol based capsule system for local long-term drug delivery. in the present study we aimed to test the in vitro release of clindamycin capsules by high performance liquid chromatography. By the end of the clinically relevant period (42 days), the capsules released 70-100% of their load. furthermore, the release kinetics suggested that an effective antimicrobial concentration may be maintained within the target area. Our findings indicate that these newly developed capsules may be a versatile device for local clindamycin delivery by providing efficient release and reducing financial burdens.

Original languageEnglish
Pages (from-to)282-284
Number of pages3
JournalJournal of Chemotherapy
Volume23
Issue number5
Publication statusPublished - Oct 2011

Fingerprint

Clindamycin
Osteomyelitis
Drug Delivery Systems
Capsules
High Pressure Liquid Chromatography
Costs and Cost Analysis
Sorbitol
Polymethyl Methacrylate
Therapeutics
Equipment and Supplies
Pharmaceutical Preparations

Keywords

  • Antibiotic release
  • Chronic osteomyelitis
  • Clindamycin
  • Infection
  • Local drug delivery
  • Local therapy
  • Polymethyl-methacrylate

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases
  • Oncology
  • Pharmacology
  • Medicine(all)

Cite this

@article{b37d862d2aee4c9a8f11d230f6abf534,
title = "Clindamycin release determined by high performance liquid chromatography from a novel low-cost local drug delivery system: A new potential treatment option for chronic osteomyelitis",
abstract = "Osteomyelitis continues to be a severe problem worldwide, causing plenty of hospital admissions and entailing vast expenses. previously, we developed a low-cost polymethyl-methacrylate (pmmA)-sorbitol based capsule system for local long-term drug delivery. in the present study we aimed to test the in vitro release of clindamycin capsules by high performance liquid chromatography. By the end of the clinically relevant period (42 days), the capsules released 70-100{\%} of their load. furthermore, the release kinetics suggested that an effective antimicrobial concentration may be maintained within the target area. Our findings indicate that these newly developed capsules may be a versatile device for local clindamycin delivery by providing efficient release and reducing financial burdens.",
keywords = "Antibiotic release, Chronic osteomyelitis, Clindamycin, Infection, Local drug delivery, Local therapy, Polymethyl-methacrylate",
author = "D. Frank and G. Montsk{\'o} and I. Juricskay and B. Borsiczky and G. Cseh and B. Kocsis and T. Nagy and Nagy, {A. K.} and G. Kov{\'a}cs and A. Miseta",
year = "2011",
month = "10",
language = "English",
volume = "23",
pages = "282--284",
journal = "Journal of Chemotherapy",
issn = "1120-009X",
publisher = "Maney Publishing",
number = "5",

}

TY - JOUR

T1 - Clindamycin release determined by high performance liquid chromatography from a novel low-cost local drug delivery system

T2 - A new potential treatment option for chronic osteomyelitis

AU - Frank, D.

AU - Montskó, G.

AU - Juricskay, I.

AU - Borsiczky, B.

AU - Cseh, G.

AU - Kocsis, B.

AU - Nagy, T.

AU - Nagy, A. K.

AU - Kovács, G.

AU - Miseta, A.

PY - 2011/10

Y1 - 2011/10

N2 - Osteomyelitis continues to be a severe problem worldwide, causing plenty of hospital admissions and entailing vast expenses. previously, we developed a low-cost polymethyl-methacrylate (pmmA)-sorbitol based capsule system for local long-term drug delivery. in the present study we aimed to test the in vitro release of clindamycin capsules by high performance liquid chromatography. By the end of the clinically relevant period (42 days), the capsules released 70-100% of their load. furthermore, the release kinetics suggested that an effective antimicrobial concentration may be maintained within the target area. Our findings indicate that these newly developed capsules may be a versatile device for local clindamycin delivery by providing efficient release and reducing financial burdens.

AB - Osteomyelitis continues to be a severe problem worldwide, causing plenty of hospital admissions and entailing vast expenses. previously, we developed a low-cost polymethyl-methacrylate (pmmA)-sorbitol based capsule system for local long-term drug delivery. in the present study we aimed to test the in vitro release of clindamycin capsules by high performance liquid chromatography. By the end of the clinically relevant period (42 days), the capsules released 70-100% of their load. furthermore, the release kinetics suggested that an effective antimicrobial concentration may be maintained within the target area. Our findings indicate that these newly developed capsules may be a versatile device for local clindamycin delivery by providing efficient release and reducing financial burdens.

KW - Antibiotic release

KW - Chronic osteomyelitis

KW - Clindamycin

KW - Infection

KW - Local drug delivery

KW - Local therapy

KW - Polymethyl-methacrylate

UR - http://www.scopus.com/inward/record.url?scp=84857718484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857718484&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 282

EP - 284

JO - Journal of Chemotherapy

JF - Journal of Chemotherapy

SN - 1120-009X

IS - 5

ER -